We act for Darnitsa, a leading Ukrainian pharmaceutical company, in a team with English and Swiss lawyers in a range of cases brought before Ukrainian and English courts with the aim to terminate an international corporate fraud scheme created by the management of a Ukrainian company in which Darnitsa is a shaholder.
Darnitsa bought a 30% stake in another major Ukrainian pharmaceutical company; years later it discovered a fraud scheme apparently arranged by that company’s top management and some of its other shareholders. The scheme which we seek to terminate allows siphoning out the profits from that company by inflating company’s expenses and transferring money to the entities affiliated with the company’s managers.
We are instructed by Darnitsa to pursue in Ukrainian courts a derivative claim against the company’s management involved in the scheme to recover damaged caused to the company. To support the Ukrainian proceedings, we sought and obtained from the High Court of Justice in London disclosure and worldwide freezing orders with regard to the assets of the corporate entities involved in the fraud.
The English court orders have been followed by the freezing order of a Swiss court enabling seizure of a multimillion amount at a Swiss bank account of the entity involved in a fraud scheme to secure future enforcement of the Ukrainian court decision.